Clinical Trials on Le Fort; I in Germany
Total 0 results
Nothing found
Sponsors and Collaborators
- John Granton
- Jeffrey Rudolph
- European Network For Smoking and Tobacco Prevention
- New York State Health Foundation
- Health Parametrics Inc.
- Kawin Technology Share-holding Co., Ltd.
- MingSight Pharmaceuticals Pty Limited
- Jeffrey W. Clark, MD
- Medtronic Atrial Fibrillation Solutions
- Marilia Medicine School
- CTC Bio, Inc.
- Zahra Rabbani Khah
- Northern California Melanoma Center
- Rex Bionics Plc
- Montreal Neurological Institute and Hospital
- Honda R and D Americas, Inc.
- Wushan County People's Hospital
- Ionis Pharmaceuticals
- The Third Hospital of Changsha
- Mitchell Scheiman
- View Full List
Medical Conditions
- Primary Generalized Dystonia
- Consequences for Nursing Home Residents and Staff of Integrating Reminiscence Into Daily Nursing Care.
- Waldenstrom's Macroglobulinemia Recurrent
- Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation
- Metastatic Spine Lesions
- Locally Advanced NSCLC
- ACTH-Secreting Pituitary Adenoma
- Pancreatic Neoplasms
- Liver Hemangioma
- Pregnancy-Related Condition, Unspecified
- Renal Cancer Metastatic
- Brain MRI
- HDT-AHCT
- Advanced Esophageal Cancers
- Ascaris Suum
- Periferal Arterial Occlusive Disease, PAOD
- LSIL
- Fasting, Diet, Chemotherapy, Toxicity
- H.Pylori Infection
- Hyperthyroidism, Autoimmune
- View Full List
Drug Interventions
- Ombrabulin (AVE8062)
- Fludarabine
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Pentostatin
- Nimotuzumab
- Rifaximin
- Levcromakalim
- Levobupivacaine, clonidine
- Toripalimab plus Anlotinib
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- Postoperative analgesia management
- Bendamustine
- AZD7798
- Hydroxychloroquine
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- ESK981
- 200 µg doxorubicin-containing MNA
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- 5-Fluoro-3-Pyridinecarboxylic Acid
- CKD-519
- View Full List
CROs by country
- Contract Research Organizations in Algeria
- Contract Research Organizations in Australia
- Contract Research Organizations in Belarus
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Estonia
- Contract Research Organizations in France
- Contract Research Organizations in Ghana
- Contract Research Organizations in Japan
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Slovenia
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Zimbabwe
- CRO list by country